Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filter.

Haddaway K, Bloch EM, Tobian AAR, Frank SM, Sikorski R, Cho BC, Zheng G, Jani J, Lokhandwala PM, Lawrence CE, Blagg L, Ness PM, Kickler TS, Gehrie EA.

Transfusion. 2019 May;59(5):1809-1817. doi: 10.1111/trf.15159. Epub 2019 Feb 11.

PMID:
30741432
2.

Blood utilization and mortality in victims of gun violence.

DeMario VM, Sikorski RA, Efron DT, Serbanescu MA, Buchanan RM, Wang EJ, Visagie M, Gehrie EA, Manukyan MC, Noll K, Ken Lee KH, Ness PM, Frank SM.

Transfusion. 2018 Oct;58(10):2326-2334. doi: 10.1111/trf.14925. Epub 2018 Sep 12.

PMID:
30209804
3.

Auditing Intraoperative Transfusions to Promote High-Value Perioperative Care.

Sikorski RA, Hensley NB, Frank SM.

Anesth Analg. 2018 May;126(5):1433-1434. doi: 10.1213/ANE.0000000000002536. No abstract available.

PMID:
29672378
4.

Thoracic Impalement by a Steel Reinforcing Bar.

Ha J, Sikorski RA, O'Connor JV.

Am Surg. 2018 Jan 1;84(1):6-8. No abstract available.

PMID:
29642976
5.

Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark.

Ehrenstein V, Andersen SL, Qazi I, Sankar N, Pedersen AB, Sikorski R, Acquavella JF.

J Rheumatol. 2017 Oct;44(10):1476-1483. doi: 10.3899/jrheum.160816. Epub 2017 Aug 1.

PMID:
28765257
6.

Physiologic Considerations in Trauma Patients Undergoing Resuscitative Endovascular Balloon Occlusion of the Aorta.

Qasim ZA, Sikorski RA.

Anesth Analg. 2017 Sep;125(3):891-894. doi: 10.1213/ANE.0000000000002215. Review.

PMID:
28640785
7.

Autologous blood salvage in the era of patient blood management.

Sikorski RA, Rizkalla NA, Yang WW, Frank SM.

Vox Sang. 2017 Aug;112(6):499-510. doi: 10.1111/vox.12527. Epub 2017 Jun 5. Review.

PMID:
28580663
8.

Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High-Energy Fracture Surgery (OXYGEN Study).

OʼToole RV, Joshi M, Carlini AR, Sikorski RA, Dagal A, Murray CK, Weaver MJ, Paryavi E, Stall AC, Scharfstein DO, Agel J, Zadnik M, Bosse MJ, Castillo RC; METRC.

J Orthop Trauma. 2017 Apr;31 Suppl 1:S25-S31. doi: 10.1097/BOT.0000000000000803. Erratum in: J Orthop Trauma. 2017 Sep;31(9):e307.

PMID:
28323798
9.

Should We Use Perioperative Transesophageal Echocardiography More in Non-Cardiac Surgery?

Williams B, Sikorski R, Anders M, Galvagno S, Rock P, Mazzeffi M.

J Cardiothorac Vasc Anesth. 2018 Jun;32(3):e71-e73. doi: 10.1053/j.jvca.2016.03.153. Epub 2016 Mar 31. No abstract available.

PMID:
27474334
10.

Helicopter emergency medical services for adults with major trauma.

Galvagno SM Jr, Sikorski R, Hirshon JM, Floccare D, Stephens C, Beecher D, Thomas S.

Cochrane Database Syst Rev. 2015 Dec 15;(12):CD009228. doi: 10.1002/14651858.CD009228.pub3. Review.

11.

Opioid use among same-day surgery patients: Prevalence, management and outcomes.

Wilson JL, Poulin PA, Sikorski R, Nathan HJ, Taljaard M, Smyth C.

Pain Res Manag. 2015 Nov-Dec;20(6):300-4. Epub 2015 Sep 10.

12.

Blood far forward: Time to get moving!

Cap AP, Pidcoke HF, DePasquale M, Rappold JF, Glassberg E, Eliassen HS, Bjerkvig CK, Fosse TK, Kane S, Thompson P, Sikorski R, Miles E, Fisher A, Ward KR, Spinella PC, Strandenes G.

J Trauma Acute Care Surg. 2015 Jun;78(6 Suppl 1):S2-6. doi: 10.1097/TA.0000000000000626.

PMID:
26002259
13.

Tranexamic acid: from trauma to routine perioperative use.

Simmons J, Sikorski RA, Pittet JF.

Curr Opin Anaesthesiol. 2015 Apr;28(2):191-200. doi: 10.1097/ACO.0000000000000165. Review.

14.

Perioperative supplemental oxygen to reduce surgical site infection: too much potential to not investigate?

O'Toole RV, Sikorski R, Castillo RC, Paryavi E, Stall A.

J Trauma Acute Care Surg. 2014 May;76(5):1332-3. doi: 10.1097/TA.0000000000000207. No abstract available.

PMID:
24747471
15.

Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study.

Bao H, Burke PA, Huang J, Chen X, Brohawn PZ, Yao Y, Lechleider RJ, Sikorski RS, Buzoianu M, Zhang J, Shi X, Richman LK, Lavallee TM.

PLoS One. 2013 Aug 21;8(8):e58557. doi: 10.1371/journal.pone.0058557. eCollection 2013.

16.

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.

De Boer RH, Kotasek D, White S, Koczwara B, Mainwaring P, Chan A, Melara R, Ye Y, Adewoye AH, Sikorski R, Kaufman PA.

Breast Cancer Res Treat. 2012 Aug;135(1):241-52. doi: 10.1007/s10549-012-2135-0. Epub 2012 Jul 29.

17.

Dual and tetraelectrode QCMs using imprinted polymers as receptors for ions and neutral analytes.

Latif U, Mujahid A, Afzal A, Sikorski R, Lieberzeit PA, Dickert FL.

Anal Bioanal Chem. 2011 Jun;400(8):2507-15. doi: 10.1007/s00216-011-4927-1. Epub 2011 Apr 3.

PMID:
21461862
18.

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer.

Huang B, Sikorski R, Sampath P, Thorne SH.

J Immunother. 2011 Apr;34(3):289-96. doi: 10.1097/CJI.0b013e31820e1b0d.

19.

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.

Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TS, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCLC Phase II Study Investigators.

Ann Oncol. 2011 Sep;22(9):2057-67. doi: 10.1093/annonc/mdq731. Epub 2011 Feb 14.

PMID:
21321086
20.

Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cells.

Contag CH, Sikorski R, Negrin RS, Schmidt T, Fan AC, Bachireddy P, Felsher DW, Thorne SH.

Cancer Res. 2010 Dec 1;70(23):9837-45. doi: 10.1158/0008-5472.CAN-10-2650. Epub 2010 Oct 8.

21.

Changing paradigms in surgical resuscitation.

Fouche Y, Sikorski R, Dutton RP.

Crit Care Med. 2010 Sep;38(9 Suppl):S411-20. doi: 10.1097/CCM.0b013e3181ec5bdf. Review.

PMID:
20724874
22.

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1.

Huang B, Sikorski R, Kirn DH, Thorne SH.

Gene Ther. 2011 Feb;18(2):164-72. doi: 10.1038/gt.2010.121. Epub 2010 Aug 26.

PMID:
20739958
23.

Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.

O'Gorman WE, Sampath P, Simonds EF, Sikorski R, O'Malley M, Krutzik PO, Chen H, Panchanathan V, Chaudhri G, Karupiah G, Lewis DB, Thorne SH, Nolan GP.

Cell Host Microbe. 2010 Aug 19;8(2):174-85. doi: 10.1016/j.chom.2010.07.008.

24.

Targeting localized immune suppression within the tumor through repeat cycles of immune cell-oncolytic virus combination therapy.

Thorne SH, Liang W, Sampath P, Schmidt T, Sikorski R, Beilhack A, Contag CH.

Mol Ther. 2010 Sep;18(9):1698-705. doi: 10.1038/mt.2010.140. Epub 2010 Jul 6.

25.

Visualizing the landscape of selection biomarkers in current phase III oncology clinical trials.

Sikorski R, Yao B.

Sci Transl Med. 2010 Jun 2;2(34):34ps27. doi: 10.1126/scitranslmed.3001087.

PMID:
20519717
26.

Parallel paths to predictive biomarkers in oncology: Uncoupling of emergent biomarker development and phase III trial execution.

Sikorski R, Yao B.

Sci Transl Med. 2009 Dec 9;1(10):10ps11. doi: 10.1126/scitranslmed.3000287.

PMID:
20368158
27.

Penetrating cardiac injury: think outside the box.

Claassen CW, O'connor JV, Gens D, Sikorski R, Scalea TM.

J Trauma. 2010 Mar;68(3):E71-3. doi: 10.1097/TA.0b013e31815edeea. No abstract available.

PMID:
20220405
28.

Traumatic atrial septal defect and papillary muscle rupture requiring mitral valve replacement after blunt injury.

Menaker J, Tesoriero RB, Hyder M, Sikorski R, Scalea TM.

J Trauma. 2009 Nov;67(5):1126. doi: 10.1097/TA.0b013e318162382e. No abstract available.

PMID:
19901679
29.

A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.

Tse AN, Klimstra DS, Gonen M, Shah M, Sheikh T, Sikorski R, Carvajal R, Mui J, Tipian C, O'Reilly E, Chung K, Maki R, Lefkowitz R, Brown K, Manova-Todorova K, Wu N, Egorin MJ, Kelsen D, Schwartz GK.

Clin Cancer Res. 2008 Oct 15;14(20):6704-11. doi: 10.1158/1078-0432.CCR-08-1006.

30.

Synthesis and biological evaluation of (-)-dictyostatin and stereoisomers.

Shin Y, Fournier JH, Brückner A, Madiraju C, Balachandran R, Raccor BS, Edler MC, Hamel E, Sikorski RP, Vogt A, Day BW, Curran DP.

Tetrahedron. 2007 Aug 27;63(35):8537-8562.

31.

A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.

Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP.

Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088.

32.

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD.

J Clin Oncol. 2008 Apr 1;26(10):1626-34. doi: 10.1200/JCO.2007.14.7116. Epub 2008 Mar 3.

33.

A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.

Vogt A, McDonald PR, Tamewitz A, Sikorski RP, Wipf P, Skoko JJ 3rd, Lazo JS.

Mol Cancer Ther. 2008 Feb;7(2):330-40. doi: 10.1158/1535-7163.MCT-07-2165. Epub 2008 Feb 1.

34.

Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.

Raccor BS, Vogt A, Sikorski RP, Madiraju C, Balachandran R, Montgomery K, Shin Y, Fukui Y, Jung WH, Curran DP, Day BW.

Mol Pharmacol. 2008 Mar;73(3):718-26. Epub 2007 Dec 11.

PMID:
18073274
35.

Total synthesis and biological evaluation of C16 analogs of (-)-dictyostatin.

Jung WH, Harrison C, Shin Y, Fournier JH, Balachandran R, Raccor BS, Sikorski RP, Vogt A, Curran DP, Day BW.

J Med Chem. 2007 Jun 28;50(13):2951-66. Epub 2007 Jun 2.

PMID:
17542572
36.

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI.

Clin Cancer Res. 2007 Mar 15;13(6):1775-82.

37.

Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.

Wipf P, Graham TH, Vogt A, Sikorski RP, Ducruet AP, Lazo JS.

Chem Biol Drug Des. 2006 Jan;67(1):66-73.

PMID:
16492150
38.

Towards a proteome-scale map of the human protein-protein interaction network.

Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M.

Nature. 2005 Oct 20;437(7062):1173-8. Epub 2005 Sep 28.

PMID:
16189514
39.

The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.

Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, Lazo JS.

J Biol Chem. 2005 May 13;280(19):19078-86. Epub 2005 Mar 7.

40.

Tunneling and coupled motion in the Escherichia coli dihydrofolate reductase catalysis.

Sikorski RS, Wang L, Markham KA, Rajagopalan PT, Benkovic SJ, Kohen A.

J Am Chem Soc. 2004 Apr 21;126(15):4778-9.

PMID:
15080672
41.

Synthesis and utility of 14C-labeled nicotinamide cofactors.

Markham KA, Sikorski RS, Kohen A.

Anal Biochem. 2004 Feb 1;325(1):62-7.

PMID:
14715285
42.

Purification, analysis, and preservation of reduced nicotinamide adenine dinucleotide 2'-phosphate.

Markham KA, Sikorski RS, Kohen A.

Anal Biochem. 2003 Nov 1;322(1):26-32.

PMID:
14705776
43.

[Nocturnal fall of blood pressure in the first half of pregnancy].

Baszak E, Baszak J, Sikorski R, Radomański T.

Ginekol Pol. 2001 Dec;72(12A):1582-7. Polish.

PMID:
11883319
44.

[Dental care during pregnancy].

Sikorska-Jaroszyńska MH, Sikorski R.

Ginekol Pol. 2001 Dec;72(12A):1572-7. Review. Polish.

PMID:
11883317
45.

[Serum levels of proinflammatory cytokines in women with uterine myomas].

Sikorski R, Kapeć E, Zaleska W.

Ginekol Pol. 2001 Dec;72(12A):1485-8. Polish.

PMID:
11883301
46.

[Serum estradiol levels in early postoperative period after surgical castration--the influence of estrogen replacement therapy].

Janeczek L, Paszkowski T, Sikorski R, Baszak E, Milart P.

Ginekol Pol. 2001 Dec;72(12A):1383-7. Polish.

PMID:
11883283
47.

[Menopausal medicine of the threshold of the third millennium].

Paszkowski T, Sikorski R, Jakiel G.

Ginekol Pol. 2001 Dec;72(12A):1370-6. Review. Polish.

PMID:
11883281
48.

[Levels of proinflammatory cytokines (Il-1 alpha, Il-6, TNF-alpha) in the semen plasma of male partners of infertile couples].

Sikorski R, Kapeć E, Krzemiński A, Zaleska W.

Ginekol Pol. 2001 Dec;72(12A):1325-8. Polish.

PMID:
11883273
49.

[Pregnancy complicated by a neoplasmatic disease].

Sikorski R.

Ginekol Pol. 2001 Dec;72(12A):1272-80. Review. Polish.

PMID:
11883263
50.

[Zoonoses in reproductive medicine].

Sikorski R, Stroczyńska-Sikorska M.

Ginekol Pol. 2001 Dec;72(12):924-30. Polish.

PMID:
11883246

Supplemental Content

Loading ...
Support Center